NPs Basic Information

Name
Chartarlactam I
Molecular Formula C23H31NO5
IUPAC Name*
(2R,3R,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-7,8-dihydro-3H-furo[2,3-e]isoindole]-6'-one
SMILES
C[C@@H]1CC[C@@H]2[C@@]([C@@]13CC4=C(C=C5C(=C4O3)CNC5=O)O)(C[C@H]([C@@H](C2(C)C)O)O)C
InChI
InChI=1S/C23H31NO5/c1-11-5-6-17-21(2,3)19(27)16(26)9-22(17,4)23(11)8-13-15(25)7-12-14(18(13)29-23)10-24-20(12)28/h7,11,16-17,19,25-27H,5-6,8-10H2,1-4H3,(H,24,28)/t11-,16-,17+,19+,22+,23-/m1/s1
InChIKey
RUBLIKRGQGISNL-QVCQCSCRSA-N
Synonyms
Chartarlactam I; CHEMBL3104968
CAS NA
PubChem CID 76313878
ChEMBL ID CHEMBL3104968
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Isoindoles and derivative
        • Subclass: Isoindolines
          • Direct Parent: Isoindolones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 401.5 ALogp: 2.8
HBD: 4 HBA: 5
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 99.0 Aromatic Rings: 5
Heavy Atoms: 29 QED Weighted: 0.535

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.35 MDCK Permeability: 0.00000449
Pgp-inhibitor: 0.009 Pgp-substrate: 0.983
Human Intestinal Absorption (HIA): 0.045 20% Bioavailability (F20%): 0.35
30% Bioavailability (F30%): 0.025

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.258 Plasma Protein Binding (PPB): 93.06%
Volume Distribution (VD): 1.122 Fu: 12.53%

ADMET: Metabolism

CYP1A2-inhibitor: 0.209 CYP1A2-substrate: 0.668
CYP2C19-inhibitor: 0.034 CYP2C19-substrate: 0.329
CYP2C9-inhibitor: 0.464 CYP2C9-substrate: 0.853
CYP2D6-inhibitor: 0.548 CYP2D6-substrate: 0.362
CYP3A4-inhibitor: 0.147 CYP3A4-substrate: 0.186

ADMET: Excretion

Clearance (CL): 10.543 Half-life (T1/2): 0.586

ADMET: Toxicity

hERG Blockers: 0.048 Human Hepatotoxicity (H-HT): 0.347
Drug-inuced Liver Injury (DILI): 0.121 AMES Toxicity: 0.01
Rat Oral Acute Toxicity: 0.963 Maximum Recommended Daily Dose: 0.952
Skin Sensitization: 0.905 Carcinogencity: 0.039
Eye Corrosion: 0.003 Eye Irritation: 0.148
Respiratory Toxicity: 0.943
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003017 1.000 D0D2TN 0.267
ENC001975 1.000 D0D1SG 0.261
ENC002009 0.816 D0KR5B 0.261
ENC003012 0.816 D08PIQ 0.256
ENC003259 0.785 D0L2LS 0.252
ENC003020 0.773 D02JNM 0.248
ENC005396 0.773 D04SFH 0.246
ENC002673 0.773 D04VIS 0.246
ENC001965 0.729 D0Y2YP 0.244
ENC003014 0.691 D0Z1FX 0.243
*Note: the compound similarity was calculated by RDKIT.